John Schuetz, PhD, is the vice-chair of the Pharmaceutical Sciences Department at St. Jude Children’s Research Hospital. View full bio.
Read how the oncogene MYCN hijacks an oxygen-carrying component of hemoglobin to feed and grow aggressive AML in children.